Ortin Laboratories

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue2.620.791.161.461.57
Expenses2.491.090.621.581.44
EBITDA0.13-0.300.54-0.120.13
EBIT0.06-0.370.47-0.150.07
Profit Before Tax0.03-0.380.45-0.210.02
Net Profit-0.430.080.46-0.200.02
Financial Ratios
Operating Profit Margin4.96%-37.97%46.55%-8.22%8.28%
Net Profit Margin-16.41%10.13%39.66%-13.70%1.27%
Earning Per Share (Diluted)-0.520.100.56-0.210.02
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ